Voloridge Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Voloridge Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,022	Closed	-$6.11M	–	1527
2021 Q4	$6.11M	Buy	+40,022	New	+$6.2M	0.03%	642
2019 Q4	–	Sell	-64,950	Closed	-$6.46M	–	1211
2019 Q3	$6.46M	Sell	64,950 -65,824	-50%	-$6.89M	0.11%	208
2019 Q2	$14.3M	Buy	+130,774	New	+$13.9M	0.39%	46
2019 Q1	–	Sell	-57,895	Closed	-$5.58M	–	985
2018 Q4	$5.58M	Buy	+57,895	New	+$6.14M	0.25%	107
2017 Q3	–	Sell	-590,205	Closed	-$61M	–	446
2017 Q2	$61M	Buy	+590,205	New	+$58.1M	1.52%	8

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Voloridge Investment Management's IBB Position: Q1 2022 in Review

Voloridge Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 40,022 shares — an estimated $6.11M sold.

Voloridge Investment Management first reported a position in IBB in Q2 2017 and held it in 5 quarters. The position peaked at $61M in Q2 2017. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Voloridge Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Voloridge Investment Management sold 40,022 iShares Biotechnology ETF shares in Q1 2022, an estimated $6.11M.
Voloridge Investment Management first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 5 quarters.
Voloridge Investment Management's iShares Biotechnology ETF position peaked at $61M in Q2 2017.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.